Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Growth factor concentrate: Use of GFC for treatment of AGA
Control Intervention1: Topical minoxidil: Use of topical minoxidil for treatment of AGA
Sponsors
srms medical college
Eligibility
Inclusion criteria
Inclusion criteria: All diagnosed with stable type of Androgenetic alopecia. Patients with hair type II-V according to Norwood-Hamilton scale for males. Patients with hair type I-II according to Ludwig scale for females. Patients who are willing to abstain from other treatments. Patients who have completed written consent form.
Exclusion criteria
Exclusion criteria: Patients who refused to participate. Patients with other type of alopecia as a diagnosis. Patients suffering from seborrheic dermatitis, tines capitis or any other scalp infection. Patients undergoing any form of chemo or radiotherapy. Patients found to be allergic to constituents of GFC. Pregnant and lactating females, chronic smokers or alcoholics. Patients who have taken any treatment for past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in hair density across 3 sittingsTimepoint: Assessment done at baseline then monthly for 3 months followed by final assessment at 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lack of improvement at the end of 6 monthsTimepoint: 6 months. | — |
Countries
India
Contacts
Public ContactDr Madhur Kant Rastogi
Shri ram murti smarak institute of medical sciences
Outcome results
None listed